The markets opened flat with the Dow slipping 8 points to 17,565 while Nasdaq rose 7 points to 4,640.
On the upside
Achillion Pharmaceuticals (Nasdaq: ACHN) reported positive interim results from a Phase 2 study of ACH-3102.
Dean Foods (NYSE: DF) fell to a loss for the third quarter but the results were better than expected and the company forecast current quarter revenue above estimates.
Orexigen Therapeutics (Nasdaq: OREX) swung to a better than expected profit for the third quarter as revenue surged.
On the downside
Rayonier (NYSE: RYN) disappointed with sharply lower third quarter earnings, lowered its dividend, cut its full year outlook and will restate financials from the first and second quarters.
Repros Therapeutics (Nasdaq: RPRX) widened losses for the third quarter as expenses climbed.
Investor locked in profits on Arch Coal (NYSE: ACI).
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by a margin of more than 10 to 9 on Nasdaq. The broader S&P 500 edged up a fraction to 2032. Bitcoin rose $15 to $372.